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Bone formation (osteogenesis) is a complex process in which cellular 
differentiation and the generation of a mineralized organic matrix are 
synchronized to produce a hybrid hierarchical architecture. To study the 
mechanisms of osteogenesis in health and disease, there is a great need 
for functional model systems that capture in parallel, both cellular and 
matrix formation processes. Stem cell-based organoids are promising as 
functional, self-organizing 3D in vitro models for studying the physiology and 
pathology of various tissues. However, for human bone, no such functional 
model system is yet available. This study reports the in vitro differentiation 
of human bone marrow stromal cells into a functional 3D self-organizing 
co-culture of osteoblasts and osteocytes, creating an organoid for early 
stage bone (woven bone) formation. It demonstrates the formation of an 
organoid where osteocytes are embedded within the collagen matrix that is 
produced by the osteoblasts and mineralized under biological control. Alike 
in in vivo osteocytes, the embedded osteocytes show network formation and 
communication via expression of sclerostin. The current system forms the 
most complete 3D living in vitro model system to investigate osteogenesis, 
both in physiological and pathological situations, as well as under the 
influence of external triggers (mechanical stimulation, drug administration).
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1. Introduction
Bone formation (osteogenesis) is a com-
plex process in which i) cellular dif-
ferentiation and ii) the generation of a 
mineralized organic matrix are synchro-
nized to produce a hybrid hierarchical 
architecture.[1] To study the molecular 
mechanisms of osteogenesis in health 
and disease, there is great need for func-
tional self-organizing 3D model systems 
that capture in parallel, both cellular 
and matrix formation processes. Such a 
self-organizing 3D model system where 
mechanical and (bio)chemical signals can 
be applied in a dynamic environment, 
would be an important tool in the devel-
opment of treatments for bone-related 
human diseases such as osteoporosis and 
osteogenesis imperfecta.
Organoids have been defined as “in vitro 
3D cellular clusters derived exclusively from 
embryonic stem cells, induced pluripotent 
stem cells or primary tissue, capable of 
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self-renewal and self-organization, and exhibiting similar 
organ functionality as the tissue of origin”, where they may 
“rely on artificial extracellular matrices (ECM) to facilitate their 
self-organization into structures that resemble native tissue 
architecture”.[2] As the development of organoids relies on 
their self-organizing nature, they also often show variability 
in their results. Nevertheless, currently organoids are those 
in vitro model systems that most closely resemble the in vivo 
situation in tissues and provide a promising approach toward 
personalized medicine. However, for human bone, no such 
functional organoid is yet available.
A crucial challenge here is the realization of a 3D system 
with different interacting bone cell types. In particular, the 
differentiation of human bone marrow-derived mesenchymal 
stromal cells (hBMSC) into osteocytes, which form 90–95% of 
the cellular fraction of bone tissue,[3] has not yet been achieved 
in vitro and currently remains a critical step in the engineering 
of in vitro human bone models.
In vivo, osteocytes form through the differentiation of osteo-
blasts, after these become embedded in the extracellular matrix 
that they produce.[3,4] Osteocytes are responsible for sensing the 
biophysical demands placed on the tissue and for orchestrating 
the concomitant actions of osteoblasts and osteoclasts in the 
remodeling of bone,[1] as well as for maintaining calcium and 
phosphate homeostasis. During the differentiation from osteo-
blasts to osteocytes, the cells grow long extensions called pro-
cesses, by which they form a sensory network that translates 
mechanical cues into biochemical signals and through which 
they interact with other cells.[1]
In vitro, osteoblast-based cell lines developed as models of 
osteocytes or osteocyte differentiation have not yet been shown 
to produce a fully developed mineralized collagen matrix,[5] and 
hence are limited in their function as 3D models for bone forma-
tion. So far, the full differentiation from mesenchymal stem cell 
(MSCs) into functional osteocytes has been demonstrated for 
mouse cells – and kept in culture for as long as a year[6] – but this 
was not yet demonstrated for human cells. Recently, pre-osteo-
cyte-like cells have been achieved from human primary cells,[7] 
and co-cultures were generated from pre-prepared populations 
of osteoblasts and osteocytes.[8] They have shown the produc-
tion of the protein podoplanin – a marker for the embedding of 
osteocytes in a mineralizing matrix – over longer time periods, 
but the direct demonstration of the in vitro production of a 3D 
bone-like mineralized matrix showing intrafibrillar mineraliza-
tion under biological control has not yet been demonstrated. 
Also missing is a demonstration of the production of sclerostin 
by osteocytes at the protein level, where sclerostin is a key 
anti-anabolic molecule that interacts with osteoblasts to down- 
regulate ECM formation. Hence, the creation of an organoid, 
as a model for developing bone, through the full differentiation 
of human primary cells into a functional osteocyte network 
within a bone-like mineralized matrix, is still an outstanding 
challenge.
As part of our efforts to realize a fully functional in vitro 
bone model, this work reports the differentiation of human 
BMSCs into a functional 3D self-organizing co-culture of osteo-
blasts and osteocytes, creating an organoid for early stage bone 
(woven bone) formation. We use a combination of immunohis-
tochemistry, 2D and 3D electron microscopy and spectroscopy 
to demonstrate that the osteocytes form a network showing 
cell–cell communication via the expression of sclerostin, 
embedded within the collagen matrix that is formed by the 
osteoblasts and mineralized under biological control.
With this extensive characterization, we demonstrate that 
this is the first fully functional 3D living in vitro model system 
for investigating the differentiation and matrix development 
processes during early bone formation.
2. Results
2.1. Differentiation of hBMSCs into a 3D Co-Culture  
of Osteoblast and Osteocytes
In the present work, primary hBMSCs were seeded on porous 
3D silk fibroin scaffolds[9] and subsequently cultured in oste-
ogenic differentiation medium. The cells were exposed to 
mechanical stimulation through fluid flow derived shear stress, 
by applying continuous stirring in a spinner-flask bioreactor 
(Figure S1, Supporting Information), while a static system was 
used as control. Cells subjected to mechanical loading showed 
the production of a mineralized extracellular matrix (ECM) – 
as assessed by micro-computed tomography (µCT) and histo-
logical staining for collagen, glycosaminoglycans, and min-
erals (Figure S2, Supporting Information). Fourier-transform 
infrared (FTIR) spectroscopy indicated a matrix composition 
similar to that of embryonic chicken bones (Figure S3, Sup-
porting Information),[10] In contrast, no significant ECM pro-
duction was observed in the static system.
The histological sections also showed that the cells migrated 
within the scaffold, forming separated colonies. As these colo-
nies present local environments, we expect the cells – as in 
any tissue – to show local variation in their degree of differen-
tiation, related to differences in local mechanical stimulation, 
local cell density, scaffold shape or location within the scaf-
fold.[11] The simultaneous presence of several different devel-
opmental stages precludes monitoring cellular differentiation 
by standard genetic screening methods such as qPCR. The dif-
ferentiation from primary cells to osteoblasts and osteocytes 
was therefore followed using immunohistochemistry, visual-
izing the expression of specific biomarkers at the protein level 
for the subsequent development to pre-osteoblasts, osteoblasts, 
and osteocytes (Figure 1; Figure S4, Supporting Information).[1] 
The pre-osteoblastic stage was identified by the expression of 
transcription factors RUNX2 (CBFA-1) and osterix (OSX, SP7) 
(Figure  1a,b; Figure S4, Supporting Information). The next 
stage in the differentiation, the formation of osteoblasts, was 
heralded by the detection of osteoblast-specific markers, where 
alkaline phosphatase (ALP) was detected at the cell surfaces, 
and osteocalcin (BGLAP), osteopontin (BSP1), and osteonectin 
(SPARC) localized in the cellular environment (Figure  1c–f; 
Figure S4, Supporting Information). Finally, the differentiation 
into osteocytes was indicated by the expression of dentin matrix 
protein1 (DMP1), podoplanin (E11), and sclerostin (Figure  1g–i; 
Figure S4, Supporting Information). DMP1 is a marker for the 
early stages of osteocyte formation, coinciding with the embed-
ding of the osteoblasts in the collagenous matrix. Podoplanin 
marks the osteocyte embedded in the non-mineralized matrix 
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stage and has been suggested to regulate cell process forma-
tion.[3] Sclerostin indicates the maturation of the osteocytes and 
their ability to perform their signaling function in the bone 
regulatory process.[1,12] We note that the rate of osteocyte dif-
ferentiation depended not only on the exposure to mechanical 
stimulation, but also on the glucose concentration in the medium, 
as indicated by the detection of sclerostin after ≈4 weeks for 
5.55 mm glucose (Figure  1i) and ≈ 8 weeks for 25 mm glucose 
(Figure 1k).
We then used fluorescence microscopy to investigate the ability 
of the cells to self-organize and form a mineralized ECM. Staining 
of the mineral with calcein showed the co-localization with scle-
rostin in large domains with dimensions of hundreds of microm-
eters, indicating the embedding of the osteocytes in a mineralized 
ECM (Figure 1k). Combined staining with calcein (mineral) and 
CNA35 (collagen) confirmed the presence of sub-millimeter sized 
mineralized collagen domains (Figure 1l) in the pores of the scaf-
fold throughout its entire volume. These mineralized domains 
co-existed with non-mineralized domains that stained positive for 
osteoblast markers (Figure S5, Supporting Information).
This implies that a co-culture had formed in which osteo-
genic cells had organized themselves according to their stage 
of differentiation and maturation, and in which the osteocytes 
had become embedded within the mineralized matrix also pro-
duced by the system.
2.2. Osteocyte Network Analysis
Although the detection of DMP1, podoplanin and sclerostin 
markers indicated the presence of osteocytes in the co-culture, 
these observations do not prove that they form a connected func-
tional network of cells. Fluorescence microscopy however con-
firmed the typical osteocyte morphology (Figure 2), showing the 
development of cell processes of >10 micrometer, as well as the 
formation of an interconnected network (Figure  2a; Figure S6, 
Supporting Information). Additionally, 3D focused ion beam/
scanning electron microscopy (3D FIB/SEM) showed that the 
cells form a relatively dense 3D network with significant varia-
tion in their morphologies, as well as in the number, length, and 
Figure 1. Differentiation of hBMSCs into osteoblasts and osteocytes: a–i) Fluorescence immunohistochemistry imaging showing markers for a–c) 
early stages of osteoblast formation, d–f) mature osteoblasts, and g–i) osteocyte development (5.55 mm glucose). Color code: red – cell cytoplasm, 
blue – cell nuclei, green: a) RUNX2 (day 7), b) OSX (day 7), c) ALP (day 26), d) osteocalcin (day 26), e) osteopontin (day 26), f) osteonectin (day 21), 
g) DMP1 (day 28), h) podoplanin (day 28), and i) sclerostin (day 28). Scale bars: 10 µm. See Figure S4, Supporting Information, for separate chan-
nels. j) Schematic illustration of MSCs differentiation into osteoblasts and osteocytes, indicating at which state which protein expression is expected 
in a–i. k,l) Fluorescent images indicating self-organized domains of osteocytes embedded in a mineralized matrix after 8 weeks (25 mm glucose), 
k) co-localization of osteocytes (sclerostin, red) and mineral (calcein, green), and l) collagen (CNA35, red) and mineral (calcein, green) * Indicates 
the silk fibroin scaffold.
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connectivity of their processes (Figure  2b–e; Tables S1 and S2, 
Supporting Information). We note that our osteocytes most often 
show flattened morphologies, which differ from those in text 
books with generally spherical or oblate bodies and long homo-
geneous protrusions, but are similar to osteocyte morphologies 
observed in different bone types, including rat tibia,[13] human 
femur,[14] and mouse woven bone.[15]
Cells showed both connected and unconnected processes, 
with connections to 1–7 neighboring cells (Figure 2f; Figure S7 
and Table S2, Supporting Information). The network had a 
density of 750 000 cells mm−3, which is higher than observed for 
mature osteocytes in cortical bone (20  000–80  000 cells mm−3),[4]  
but in line with numbers found for woven bone such as in 
embryonic chicken tibia (500 000–700 000 cells mm−3).[16] Image 
analysis (Figure S8, Supporting Information) shows that for 
the different cells, the number of processes per unit surface 
area ranged between 0.05–0.23 µm−2 (Table S3, Supporting 
Information), in line with values reported for mouse osteocytes 
(0.08– 0.09  µm−2).[17] The functionality of the processes was 
indicated not only by their connection to neighboring cells 
Figure 2. Osteocyte development and network formation. a) Fluorescent cytoplasm staining showing the development of long (>5 µm, arrows) cell 
processes connecting cells, and the formation of an interconnected network. The long processes were enhanced using a gamma value of −1.5. (see 
original image in Figure S6, Supporting Information). b) 3D FIB/SEM reconstruction showing cell morphology and network formation in the whole 
volume. c–e) Details from the 3D reconstruction in (b) showing individual osteocytes in different stages of morphological development (cell numbers 
refer to identification in Figure S7, Supporting Information). c) Cell #7, d) cell #9, e) cell #14. f–i) Cell connectivity: f) Connectivity map of the cells in 
the 3D FIB/SEM stack (see also Tables S1 and S2, Supporting Information). Sizes of the circles reflect the number of processes of that respective cell. 
Thickness of the lines reflects the number of connections between individual cells (cell numbers refer to identification in Figure S7, Supporting Infor-
mation). g) single slice from the 3D FIB/SEM stack showing long processes (arrow), creating a cellular network. h) TEM image shows a gap junction 
between processes of two connecting cells. i) fluorescent immunohistochemistry showing the presence of gap junctions on the surface of the different 
cells. Color code: red – cell cytoplasm, blue – cell nuclei, green – connexin43.
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(Figure 2g,h), but also by their co-localization with connexin43, 
a protein essential for gap junction communication (Figure 2i).[1] 
The observed variation in osteocyte morphology, together with 
the variation in the number of cell processes per surface area 
reflects the different stages of development and maturation, as 
expected in a differentiating osteogenic co-culture.
Hence, the osteocytes in our 3D in vitro system not only 
have the ability to organize themselves as a connective cellular 
network within a mineralized collagen matrix, but also show 
the capability to perform cell–cell communication.
2.3. Characterization of the Extracellular Matrix
Although it is essential that a 3D in vitro model for bone for-
mation shows the relevant developmental stages, self-organi-
zation and cell–cell communication, its physiological relevance 
critically depends on its capability to reproduce the bone extra-
cellular matrix. The formation and maintenance of a collagen–
mineral hybrid tissue in vitro has previously been demonstrated 
using second harmonic generation imaging,[18] Raman spec-
troscopy,[19] and X-ray based techniques.[20] Here, we therefore 
investigated the ability of our living in vitro system to form a 
functional ECM, in which collagen is mineralized under bio-
logical control (Figure 3).
FIB/SEM volume imaging with 3D reconstruction showed 
that the osteocytes were fully embedded in their ECM 
(Figure  3a; Video S1, Supporting Information). The pro-
duced collagen matrix enveloped the cells, but showed a low 
degree of long range order (Figure  3b), as known for woven 
bone.[15,21] and in line with what was described for collagen 
layers containing osteocytes.[22] The extracellular deposition of 
non-collagenous proteins (NCPs) was evidenced by immuno-
histochemical analysis, showing the presence of osteocalcin, 
osteopontin, and DMP1 and their co-localization with collagen 
(Figure 3c,d; Figure S9, Supporting Information).
Whereas µCT (Figure S2, Supporting Information), 
FTIR (Figure S3, Supporting Information), histochemistry 
(Figure S2, Supporting Information), and fluorescence micros-
copy (Figure 1k) all indicated the mineralization of the organic 
matrix, none of these methods can provide the spatial resolu-
tion to demonstrate whether the mineral crystals are indeed, as 
in bone, co-assembled with the collagen fibrils,[23] and not just 
the result of uncontrolled precipitation.[24] We therefore applied 
a multiscale imaging approach to verify that matrix minerali-
zation indeed occurred under biological control. Raman micro-
spectroscopy of the extracellular matrix showed the spectral 
signature of developing bone (Figure  3f) and confirmed the 
co-localization of the mineral with the collagen (Figure S10, 
Supporting Information. Spectral analysis further confirmed 
that the mineral/matrix ratio (a key parameter for bone devel-
opment, determined from the PO4 ν4/Amide III vibrations 
intensity ratio[25]) in the co-culture was indeed in the range 
found for developing bone (Figure 3g).[26]
At higher resolution (voxel size 10 × 10 × 20 nm3), 3D FIB/
SEM with back scatter detection revealed thin collagen fibrils 
(diameters 50–80  nm) with varying degrees of mineraliza-
tion as also commonly observed in the early stages of bone 
development (Figure  3i; Video S2 and Figure S11, Supporting 
Information).[27] Applying a heat map presentation showed the 
coexistence of non-mineralized fibrils (blue) alongside a min-
eralized population (green-red range). Additionally, transmis-
sion electron microscopy (TEM) showed mineralized single 
fibrils,[6a] indicating that the collagen matrix was indeed min-
eralized under biological control (Figure  3j).[28] Nevertheless, 
in some areas also, larger mineral precipitates were observed 
(Figure S10 c, orange, Supporting Information) (Video S2, Sup-
porting Information), possibly due to local non-biologically con-
trolled precipitation of calcium phosphate.
3. Discussion
Woven bone is the first form of mammalian bone deposited during 
embryonic development and fracture, before being replaced by 
other bone types.[21] This is typically the case in situations in which 
rapid formation is a prime concern, and where osteoclasts and 
bone remodeling do not yet play a role. Our results show the for-
mation of a bone organoid consisting of a self-organized co-culture 
of osteoblasts and osteocytes representing a functional model for 
woven bone, an early state of bone formation in which the collagen 
matrix is still disorganized and distinct from the more mature 
ordered 3D structure.[23] We demonstrate the functionality of the 
organoid by showing that the ECM formed by the osteoblasts is 
mineralized under biological control, and that the mature osteo-
cytes self-organize into a network within the mineralized matrix 
where they express sclerostin and connexin43 at the protein level.
Interestingly, the production of sclerostin did not prohibit ECM 
formation throughout the organoid, suggesting that the down 
regulation of this process is a local effect. This may be explained 
by assuming the most mature osteocytes are in the center of the 
osteocyte domains, which would lead to a gradient of sclerostin 
decreasing towards the periphery of the network, only affecting 
the activity of the osteoblasts closest to the osteocyte domain.
The use of silk fibroin as a scaffold material rather than the 
frequently used collagen scaffolds, permits to differentiate 
between the supplied and the newly formed matrix material, and 
study the quality of the collagen matrix as function of external 
stimuli (mechanical load, therapeutics) or genetic diseases (e.g., 
osteogenesis imperfecta). The application of mechanical stimula-
tion during the development of our stem cell based co-culture 
proved crucial for the osteogenic differentiation, and underlines 
the importance of the integration of self-organizing stem cell 
based strategies with environmental control in microfluidic sys-
tems in the recent organoid-on-a-chip approaches.[29]
4. Conclusion
Summarizing, we conclude that we have generated an organoid 
for woven bone. The ability of this self-organizing 3D co-culture 
of osteoblasts and osteocytes to form an organic matrix that is 
mineralized under biological control, is currently the most com-
plete human in vitro model system for bone formation. It intro-
duces the ability to closely monitor both cellular and matrix 
formation processes and will thereby provide new unique pos-
sibilities for the study of genetic bone related diseases, and the 
development of personalized medicine.
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Figure 3. ECM development: a) 3D FIB/SEM reconstruction shows the embedding of the cells in the collagen matrix (cyan). Discrete cells are repre-
sented with different colors. b) TEM image of a 70 nm section showing the random distribution of collagen fibrils. Collagen type I was identified by 
immunolabelling. c–e) Fluorescent immunohistochemistry identifying key non-collagenous proteins in the collagenous matrix: c) Co-localization of 
osteocalcin (green) and collagen (red). d) Osteopontin (green) distribution in the collagen matrix (red). * Indicates the silk fibroin scaffold. e) Co-local-
ization of DMP1 (green) with the collagen structure (see Figure S5, Supporting Information, for collagen image). f–g) Raman microspectrometry of 
mineralized matrices. f) Localized Raman spectra of mineralized collagen of developing zebrafish bone (red), the 3D osteogenic co-culture (blue), 
and human bone of a 10 year old female (grey g) Raman derived mineral/matrix ratios of 4 mineralized tissues of zebrafish (N = 6, red), Osteogenic 
3D culture (N = 7, green), 10 year old human female (N = 1, grey), and 48+ years old human male (N = 7, black, taken from ref. [36]). Bars indicate 
sample standard deviations. h) Heat map presentation of a 3D FIB/SEM cross section showing disorganized collagen fibrils with different degrees of 
mineralization (Figure S10, Supporting Information). Arrowheads indicate non-mineralized collagen fibrils (light blue), arrow indicates mineralized 
collagen fibril (orange). i) TEM image showing individual mineralized collagen fibrils.
Adv. Funct. Mater. 2021, 31, 2010524
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5. Experimental Section
Materials: Dulbecco’s modified Eagle medium (DMEM high glucose 
Catalogue No. 41 966 and low glucose Cat. No. 31 885) and antibiotic/
antimycotic (Anti-Anti) were from Life Technologies (Bleiswijk, The 
Netherlands). Citrate buffer was from Thermo Fisher Scientific (Breda, The 
Netherlands). Methanol was from Merck (Schiphol-Rijk, The Netherlands). 
Trypsin-EDTA (0.25%) was from Lonza (Breda, The Netherlands). Fetal 
bovine serum (FBS) was from PAA Laboratories (Cat. No A15-151, 
Cölbe, Germany). 10-nm Au particles conjugated to Protein-A were from 
CMC, UMC Utrecht (Utrecht, The Netherlands). BSA-c was from Aurion 
(Wageningen, The Netherlands). Silkworm cocoons from Bombyx mori 
L. were purchased from Tajima Shoji Co., LTD. (Yokohama, Japan). All 
other substances were of analytical or pharmaceutical grade and obtained 
from Sigma–Aldrich (Zwijndrecht, The Netherlands). The reference human 
bone sample used for Raman micro-spectrometry was waste material 
from a surgical procedure on a fractured left tibia of a 10-year-old female. 
According to the Central Committee on Research involving Human Subjects 
(CCMO), this type of study does not require approval from an ethics 
committee in the Netherlands (see https://english.ccmo.nl/investigators/
legal-framework-for-medical-scientific-research/your-research-is-it-subject-
to-the-wmo-or-not). Information on the embryonic chicken bone and 
zebrafish bone was gathered from ref. [15] (Kerschnitzky et al.) and ref. [23] 
(Akiva et al.), respectively.
Scaffold Fabrication: Silk fibroin scaffolds were produced as 
previously described.[30] Briefly, Bombyx mori L. silkworm cocoons 
were degummed by boiling in 0.2 m Na2CO3 twice for 1 h. The dried 
silk was dissolved in 9 m LiBr and dialyzed against ultra-pure water 
(UPW) for 36 h using SnakeSkin Dialysis Tubing (molecular weight 
cutoff: 3.5 K; Thermo Fisher Scientific, Breda, The Netherlands). 
Dialyzed silk fibroin solution was frozen at −80 °C and lyophilized 
(Freezone 2.5, Labconco, Kansas City, MO, USA) for 4 days, then 
dissolved in hexafluoro-2-propanol, resulting in a 17% (w/v) solution. 
Dissolved silk fibroin (1 mL) was added to NaCl (2.5 g) with a granule 
diameter of 250–300  µm and was allowed to air dry for 3 days. Silk-
salt blocks were immersed in 90% MeOH for 30 min to induce β-sheet 
formation.[31] NaCl was extracted from dried blocks in UPW for 2 days. 
Scaffolds were cut into disks of 5 mm in diameter and 3 mm in height 
and autoclaved in PBS at 121 °C for 20 min.
Cell Culture: Cells were isolated from unprocessed, fresh, human bone 
marrow (Lonza, Walkersville, MD, USA, cat. No #1M-125) of one male 
donor (healthy, non-smoker). hBMSCs isolation and characterization 
was performed as previously described and passaged up to passage 4.[30]  
Pre-wetted scaffolds were seeded with 1 million cells each in 20 µL control 
medium (DMEM, 10% FBS, 1% Anti-Anti) and incubated for 90  min at 
37 °C. The cell-loaded scaffolds were transferred to custom-made spinner 
flask bioreactors (n = 4 per bioreactor, Figure S1, Supporting Information). 
Each bioreactor contained a magnetic stir bar and was placed on a 
magnetic stirrer (RTv5, IKA, Germany) in an incubator (37  °C, 5% 
CO2). Each bioreactor was filled with 5 mL osteogenic medium (control 
medium, 50 µg.mL−1 ascorbic-acid-2-phosphate, 100 nm dexamethasone, 
and 10 mm β-glycerophosphate) and medium was changed three times 
a week.
Micro-Computed Tomography Imaging (µCT): µCT measurements 
and analysis were performed on a µCT100 imaging system (Scanco 
Medical, Brüttisellen, Switzerland). Scanning of the co-culture samples 
within the bioreactor was performed at an isotropic nominal resolution 
of 17.2 µm, energy level was set to 45 kVp, intensity to 200 µA, 300 ms 
integration time and twofold frame averaging. A constrained Gaussian 
filter was applied to reduce part of the noise. Filter support was set to 
1.0 and filter width sigma to 0.8 voxel. Filtered grayscale images were 
segmented at a global threshold of 23% of the maximal grayscale value 
to separate the mineralized tissue from the background and binarize 
the image. Unconnected objects smaller than 50 voxels were removed 
and neglected for further analysis. Quantitative morphometrical analysis 
was performed to assess mineralized ECM volume within the entire 
scaffold volume using direct microstructural bone analysis as previously 
described for human bone biopsies.[32]
Histological Analysis: Fixation and Sectioning: Co-cultures were fixed in 
10% neutral buffered formalin (24 h at 4 °C), dehydrated in serial ethanol 
solutions (50%, 70%, 90%, 96%, 100%, 100%, 100%), embedded in 
paraffin, cut into 6  µm thick sections and mounted on Poly-L-Lysine 
coated microscope slides. Paraffin sections were dewaxed with xylene 
and rehydrated to water through graded ethanol solutions.
Brightfield Imaging: Sections were stained with Alizarin Red to 
identify mineralization (2%, Sigma–Aldrich), Picrosirius Red (0.1%, 
Sigma–Aldrich) to identify collagen, Alcian blue (1%, Sigma–Aldrich) to 
identify Glycosaminoglycan (GAGs). Sections were imaged using Zeiss 
Axio Observer Z1 microscope.
Immunohistochemistry: Antigen retrieval in pH 6 citrate buffer at 95 °C 
was performed for 20  min. Sections were washed three times in PBS. 
Non-specific antibody binding was blocked with 5% serum (v/v) from 
the host of the secondary AB and 1% bovine serum albumin (w/v) in 
PBS (blocking buffer) for 1 h. Sections were then incubated overnight at 
4 °C with primary antibodies in blocking buffer. The sections were rinsed 
with PBS four times for 5  min and incubated for 1 h with secondary 
antibodies in blocking buffer and at times with calcein solution (1 µg.mL−1, 
C0875 Sigma–Aldrich). All used antibodies and dyes are listed in Table 1. 
Nuclei were stained with DAPI for 5 min, after which sections were again 
washed three times with PBS and mounted on microscope glass slides 
with Mowiol. Cytoplasm was stained with FM 4–64 (Molecular Probes 
cat#T3166) for 1 min and followed by washing the sections three times 
with PBS. Except for primary antibody incubation, all incubation steps 
were performed at room temperature. Sections were imaged either by 
Zeiss Axiovert 200M microscope (large field of view) or by Leica TCS 
SP5X (x63, high magnification images). Images were post processed 
(brightness, contrast, channel merging, and crop) using Fiji software.
Electron Microscopy: Sample Preparation for Electron Microscopy: 
Samples were processed for electron microscopy as previously 
described.[33] In short, co-culture samples were fixed in 2.5% 
glutaraldehyde and 2% paraformaldehyde in 0.1 m sodium cacodylate 
buffer (CB) for 72 h and washed five times in 0.1 m CB and five times in 
double-distilled water (ddH2O). Co-cultures were then post fixed using 
1% OsO4 with 0.8% K3Fe(CN)6 in 0.1 m CB for 1 h on ice. After rinsing 
in 0.1 m CB, the co-cultures were treated with 1% tannic acid followed 
by 1% uranyl acetate in ddH2O for 1 h. Finally, the samples were rinsed 
using ddH2O, dehydrated with ethanol (50%, 70%, 90%, 96%, 100%), 
and embedded in Epon resin.
Focused Ion Beam Scanning Electron Microscopy (FIB/SEM) Imaging: 
Epon embedded samples were imaged with a Scios FIB/SEM (Thermo 
Fisher Scientific, Breda, The Netherlands) under high vacuum 
conditions. Using the gas injection system (GIS) in the FIB/SEM 
microscope, a 500 nm thick layer of Pt was deposited over the ROI, at 
an acceleration voltage of 30 kV and a current of 1 nA. Trenches flanking 
the ROI were milled at an acceleration voltage of 30 kV, using a high FIB 
beam current (5–7 nA), followed by a staircase pattern in front of the 
ROI to expose the imaging surface. Fine polishing was performed with 
the ion beam set to 30 kV with a FIB beam current of 0.5 nA, resulting in 
a smooth imaging surface. Serial imaging was then performed using the 
in-column backscattered electron detector, and the following settings: 
Acceleration voltage 2 kV, Beam current 0.2 nA, Pixel dwell time 10 µs, 
voxel size: 30 × 30 × 30 nm (stack in Video S1, Supporting Information) 
and 10 × 10 × 20 nm (stack in Video S2, Supporting Information).
Sample Preparation for Transmission Electron Microscopy (TEM): Epon 
embedded samples: 70 nm sections from resin embedded blocks were 
made using an ultra-microtome (Leica), and collected on carbon coated 
copper TEM grids. Post staining with uranyl acetate and led citrate was 
performed using the Leica EM AC20 automatic contrasting instrument.
Preparation and Immunogold Labeling of Tokuyasu Sections: Thin 
sections were prepared following the Tokuyasu protocol.[34] Briefly, 
co-cultures were fixed as described above and infiltrated overnight in 
2.3 m sucrose for cryo-protection. Small blocks of the co-cultures were 
mounted on aluminum pins and plunge frozen in liquid nitrogen. 70 nm 
thick cryosections were sectioned with a cryo-ultramicrotome and picked 
up with a mixture of 2% methylcellulose/2.3 m sucrose on copper 
support grids coated with formvar and carbon. After rinsing away the 
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pick-up solution in PBS at 37 °C for 30 min, the sections were treated 
with PBS containing 0.15% glycine, followed by blocking for 10 min with 
0.5% cold fish skin gelatin and 0.1% BSA-c in PBS. The TEM grids were 
incubated for 1 h with a collagen type 1 antibody in blocking solution 
(Abcam, AB34710). The grids were then rinsed with 0.1% BSA in PBS and 
incubated with 10-nm Au particles conjugated to Protein-A in blocking 
solution.[35] The sections were then thoroughly washed in ddH2O, 
stained with uranyl acetate and embedded in methylcellulose.[35]
TEM Imaging: The sections were imaged using a Tecnai T12 TEM 
(80kV)  (Thermo Fisher Scientific, Breda, The Netherlands), equipped 
with Veleta (EMSIS GmbH, Münster, Germany).
Raman Spectroscopy: Raman measurements were conducted using 
a WiTec Alpha 300R confocal Raman microscope. Co-culture samples 
were fixed in 10% neutral buffered formalin (24 h at 4 °C), incubated 
for 2 h in 5% sucrose at 4 °C, embedded in Tissue-Tek (Sakura Finetek 
4 609 024), cut into 10 µm thick sections, and mounted on Poly-L-Lysine 
coated microscope slides. Raman imaging was conducted using 532 nm 
excitation lasers with a laser power of 10 mW, using 50 × 0.8 objective 
(0.8 NA) with a grating of 600 mm−1. The maps were obtained with a 
spatial resolution of 3 spectra.µm−1. Data analysis was performed using 
Project V plus software (Witec, Ulm) and Origin 8.
FTIR Spectroscopy: Prior to the FTIR measurement, the co-culture 
samples were freeze dried overnight. After drying, 1.5 mg of the samples 
was crushed using mortar and pestle until a fine powder was achieved. 
After this, 148.5  mg of KBr was added to the mortar and pestle and 
the materials were mixed and further crushed to a fine homogeneous 
mixture. The mixture was added to a pellet press holder; the transparent 
and homogeneous pellets were then inserted into the FTIR spectrometer 
(Perking Elmer one 1600). The FTIR spectra were obtained in 
transmission mode. Spectra were obtained over the range from 200 to 
6000 cm−1 with a spectral resolution of 0.5 cm−1.
Image Analysis: 3D FIB/SEM Image processing was performed using 
Matlab and Avizo 3D software (FEI VSG, www.avizo3d.com). 3D image 
reconstruction, alignment, denoising, and brightness and contrast 
adjustments were done usign Matlab. 3D segmentation was done using 
Avizo. Segmentation was performed using manual thresholding, and 
cell processes were counted manually. As all cells were only partially 
captured in the available FIB/SEM volume, cell process density was 
determined per unit surface area of the cell body. The surface areas of 
cell parts captured in the FIB/SEM volume were calculated from the 
segmented 3D image mask using Matlab and Fiji. Further details are 
given in Figure S11, Supporting Information.
Cell density was determined from the number of cells in the imaged 
FIB/SEM volume (20 µm x 20 µm x 40 µm) and compared to literature 
data from histological sections (volume 5 µm x 1000 µm x 1000 µm).[16]
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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